Abbott Laboratories Ltd lowering its 2022 sales forecast due to its ongoing recall of Similac and other infant formulas won’t surprise anyone, but a rapid recovery of market share in the category might.
The firm on 20 April reported its worldwide nutrition sales, which include adult as well as infant products, during the...







